Cambridge Investment Research Advisors’s Innovator Equity Defined Protection ETF - 2 Yr to January 2027 TJAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Sell
7,121
-6,980
-50% -$195K ﹤0.01% 3838
2026
Q1
$382K Sell
14,101
-75
-0.5% -$2.05K ﹤0.01% 3055
2025
Q4
$387K Sell
14,176
-981
-6% -$26.6K ﹤0.01% 2959
2025
Q3
$410K Hold
15,157
﹤0.01% 2843
2025
Q2
$399K Buy
15,157
+589
+4% +$15.1K ﹤0.01% 2749
2025
Q1
$369K Buy
+14,568
New +$373K ﹤0.01% 2697

Other funds holding TJAN

Cambridge Investment Research Advisors's TJAN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Innovator Equity Defined Protection ETF - 2 Yr to January 2027 (TJAN) stake by 50% in Q2 2026, selling an estimated $195K and leaving 7,121 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #3838.

Cambridge Investment Research Advisors first reported a position in TJAN in Q1 2025 and has held it in 6 quarters since. The position peaked at $410K in Q3 2025. 8 funds tracked by Wall St. Rank hold TJAN as of Q2 2026.

  • Cambridge Investment Research Advisors held 7,121 shares of Innovator Equity Defined Protection ETF - 2 Yr to January 2027 worth $200K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 6,980 Innovator Equity Defined Protection ETF - 2 Yr to January 2027 shares in Q2 2026, an estimated $195K.
  • Innovator Equity Defined Protection ETF - 2 Yr to January 2027 made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3838 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator Equity Defined Protection ETF - 2 Yr to January 2027 in Q1 2025 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's Innovator Equity Defined Protection ETF - 2 Yr to January 2027 position peaked at $410K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 2 Yr to January 2027 as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.